Laboratory of Biophotonics and Pharmacology


Logo Universite de strasbourg


On this website

On the whole CNRS Web

Home page > Experimental Pharmacology > Publications

Publication 2017

4 April 2017

M. ABBAS, L. JESEL, C. AUGER, L. AMOURA, N. MESSAS, G. MANIN, C. RUMIG, A.J. LEON-GONZALEZ, T.P. RIBEIRO, G.C. SILVA, R. ABOU-MERHI, E. HAMADE, M. HECKER, Y. GEORG, N. CHAKFE, P. OHLMANN, V.B. SCHINI-KERTH, F. TOTI & O. MOREL. Endothelial microparticles from acute coronary syndrome patients induce premature coronary artery endothelial cells ageing and thrombogenicity: role of the Ang II/AT1 receptor/NADPH oxidase-mediated activation of MAPKs and PI3-kinase pathways. Circulation 135, 280-296, 2017 IF 17.20 – EQ3

K. ELHABAZI, J.P. HUMBERT, I. BERTIN, R. QUILLET, V. UTARD, S. SCHNEIDER, M. SCHMITT, J.J. BOURGUIGNON, E. LABOUREYRAS, M. BEN BOUJEMA, G. SIMONNET, C. ANCEL, V. SIMONNEAUX, M. BELTRAMO, B. BUCHER, T. SORG, H. MEZIANE, E. SCHNEIDER, B. PETIT-DEMOULI, B. ILIEN, F. BIHEL & F. SIMONIN. RF313, an orally bioavailable neuropeptide FF receptor antagonist, opposes effects of RF-amide-related peptide-3 and opioid-induced hyperalgesia in rodents. Neuropharmacology 118, 188-198, 2017 IF 4.94 – EQ3